Education
About Us
Working with TipRanks
Follow Us
IGC Pharma (IGC)
XASE:IGC
| Mar 25 | Mar 24 | Jun 23 | Mar 22 | Mar 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.27M | $ 1.34M | $ 911.00K | $ 397.00K | $ 898.00K |
| Gross Profit | $ 619.00K | $ 733.00K | $ -158.00K | $ 194.00K | $ -349.00K |
| Operating Income | $ -7.45M | $ -9.80M | $ -11.57M | $ -15.43M | $ -8.72M |
| EBITDA | $ -6.83M | $ -9.16M | $ -10.85M | $ -14.37M | $ -8.33M |
| Net Income | $ -7.12M | $ -13.00M | $ -11.51M | $ -15.02M | $ -8.81M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 405.00K | $ 1.20M | $ 3.35M | $ 10.46M | $ 14.63M |
| Total Assets | $ 8.75M | $ 9.90M | $ 17.18M | $ 26.83M | $ 35.87M |
| Total Debt | $ 238.00K | $ 348.00K | $ 481.00K | $ 611.00K | $ 1.07M |
| Net Debt | $ -167.00K | $ -850.00K | $ -2.71M | $ -9.85M | $ -13.47M |
| Total Liabilities | $ 2.42M | $ 2.58M | $ 2.27M | $ 2.94M | $ 3.06M |
| Stockholders' Equity | $ 6.33M | $ 7.32M | $ 14.91M | $ 23.89M | $ 32.80M |
| Cash Flow | |||||
| Free Cash Flow | $ -5.28M | $ -5.71M | $ -7.67M | $ -8.23M | $ -12.39M |
| Operating Cash Flow | $ -4.79M | $ -5.20M | $ -7.05M | $ -7.46M | $ -10.80M |
| Investing Cash Flow | $ -442.00K | $ -317.00K | $ -235.00K | $ -742.00K | $ 3.39M |
| Financing Cash Flow | $ 4.45M | $ 3.52M | $ 100.00K | $ 4.14M | $ 14.69M |
IGC Pharma Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.